Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

178 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic value of the SPOP mutant genomic subclass in prostate cancer.
Shoag J, Liu D, Ma X, Oromendia C, Christos P, Ballman K, Angulo C, Cai PY, Gaffney C, Klein E, Karnes J, Den RB, Liu Y, Davicioni E, Barbieri CE. Shoag J, et al. Among authors: karnes j. Urol Oncol. 2020 May;38(5):418-422. doi: 10.1016/j.urolonc.2020.02.011. Epub 2020 Mar 17. Urol Oncol. 2020. PMID: 32192889
Cell cycle-coupled expansion of AR activity promotes cancer progression.
McNair C, Urbanucci A, Comstock CE, Augello MA, Goodwin JF, Launchbury R, Zhao SG, Schiewer MJ, Ertel A, Karnes J, Davicioni E, Wang L, Wang Q, Mills IG, Feng FY, Li W, Carroll JS, Knudsen KE. McNair C, et al. Among authors: karnes j. Oncogene. 2017 Mar 23;36(12):1655-1668. doi: 10.1038/onc.2016.334. Epub 2016 Sep 26. Oncogene. 2017. PMID: 27669432 Free PMC article.
Two positive nodes represent a significant cut-off value for cancer specific survival in patients with node positive prostate cancer. A new proposal based on a two-institution experience on 703 consecutive N+ patients treated with radical prostatectomy, extended pelvic lymph node dissection and adjuvant therapy.
Briganti A, Karnes JR, Da Pozzo LF, Cozzarini C, Gallina A, Suardi N, Bianchi M, Freschi M, Doglioni C, Fazio F, Rigatti P, Montorsi F, Blute ML. Briganti A, et al. Eur Urol. 2009 Feb;55(2):261-70. doi: 10.1016/j.eururo.2008.09.043. Epub 2008 Oct 1. Eur Urol. 2009. PMID: 18838212
Predicting prostate cancer-specific outcome after radical prostatectomy among men with very high-risk cT3b/4 PCa: a multi-institutional outcome study of 266 patients.
Moltzahn F, Karnes J, Gontero P, Kneitz B, Tombal B, Bader P, Briganti A, Montorsi F, Van Poppel H, Joniau S, Spahn M. Moltzahn F, et al. Among authors: karnes j. Prostate Cancer Prostatic Dis. 2015 Mar;18(1):31-7. doi: 10.1038/pcan.2014.41. Epub 2014 Dec 23. Prostate Cancer Prostatic Dis. 2015. PMID: 25535100
A Multi-institutional Analysis of Perioperative Outcomes in 106 Men Who Underwent Radical Prostatectomy for Distant Metastatic Prostate Cancer at Presentation.
Sooriakumaran P, Karnes J, Stief C, Copsey B, Montorsi F, Hammerer P, Beyer B, Moschini M, Gratzke C, Steuber T, Suardi N, Briganti A, Manka L, Nyberg T, Dutton SJ, Wiklund P, Graefen M. Sooriakumaran P, et al. Among authors: karnes j. Eur Urol. 2016 May;69(5):788-94. doi: 10.1016/j.eururo.2015.05.023. Epub 2015 May 30. Eur Urol. 2016. PMID: 26038098
Editorial comment.
Karnes JR. Karnes JR. J Urol. 2014 Jul;192(1):110-1. doi: 10.1016/j.juro.2013.12.068. Epub 2014 Mar 28. J Urol. 2014. PMID: 24685567 No abstract available.
A risk calculator predicting recurrence in lymph node metastatic penile cancer.
Bandini M, Spiess PE, Pederzoli F, Marandino L, Brouwer OR, Albersen M, Roussel E, de Vries HM, Chipollini J, Zhu Y, Ye DW, Ornellas AA, Catanzaro M, Hakenberg OW, Heidenreich A, Haidl F, Watkin N, Ager M, Ahmed ME, Karnes JR, Briganti A, Salvioni R, Montorsi F, Azizi M, Necchi A. Bandini M, et al. Among authors: karnes jr. BJU Int. 2020 Nov;126(5):577-585. doi: 10.1111/bju.15177. Epub 2020 Aug 7. BJU Int. 2020. PMID: 32662205
178 results